NATCO Pharma Management
Management criteria checks 4/4
NATCO Pharma's CEO is Rajeev Nannapaneni, appointed in Jun 2012, has a tenure of 11.92 years. directly owns 0.63% of the company’s shares, worth ₹1.15B. The average tenure of the management team and the board of directors is 7.3 years and 9.4 years respectively.
Key information
Rajeev Nannapaneni
Chief executive officer
₹20.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.9yrs |
| CEO ownership | 0.6% |
| Management average tenure | 7.3yrs |
| Board average tenure | 9.4yrs |
Recent management updates
Recent updates
Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03
NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02NATCO Pharma's (NSE:NATCOPHARM) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 22Estimating The Intrinsic Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
Feb 16Here's Why NATCO Pharma (NSE:NATCOPHARM) Has A Meaningful Debt Burden
Nov 30Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 24These 4 Measures Indicate That NATCO Pharma (NSE:NATCOPHARM) Is Using Debt Reasonably Well
Mar 22Should NATCO Pharma Limited (NSE:NATCOPHARM) Be Part Of Your Dividend Portfolio?
Mar 04CEO
Rajeev Nannapaneni (46 yo)
11.9yrs
Tenure
₹20,920,000
Compensation
Sri Rajeev Nannapaneni serves as Chief Executive Officer at NATCO Pharma Limited since April 1, 2022 and also served as Vice Chairman since June 1, 2012 until April 1, 2022 and serves as its Vice Chairman...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 42.7yrs | ₹22.68m | 25.1% ₹ 45.8b | |
| CEO & Vice Chairman | 11.9yrs | ₹20.92m | 0.63% ₹ 1.1b | |
| Chief Financial Officer | 8.3yrs | ₹13.00m | no data | |
| President of Technical Affairs & Whole Time Director | no data | ₹32.30m | 0.030% ₹ 55.1m | |
| Company Secretary & Compliance Officer | 2.1yrs | ₹3.00m | no data | |
| Executive VP of Corporate Engineering Services & Whole Time Director | no data | ₹19.20m | 0.026% ₹ 47.0m | |
| Executive VP of Technical Operations & Director | 7.3yrs | ₹54.50m | no data | |
| Senior Vice President of Operations | no data | no data | no data | |
| Executive Vice President of Corporate Affairs | no data | no data | no data | |
| Vice President of Marketing & Sales - Domestic | less than a year | no data | no data | |
| Senior Vice President of HR & Organisational Development | no data | no data | 0.0062% ₹ 11.3m | |
| Executive Vice President of R&D | 30.1yrs | no data | no data |
7.3yrs
Average Tenure
64yo
Average Age
Experienced Management: NATCOPHARM's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 42.7yrs | ₹22.68m | 25.1% ₹ 45.8b | |
| CEO & Vice Chairman | 18.5yrs | ₹20.92m | 0.63% ₹ 1.1b | |
| President of Technical Affairs & Whole Time Director | 9.3yrs | ₹32.30m | 0.030% ₹ 55.1m | |
| Executive VP of Corporate Engineering Services & Whole Time Director | 9.5yrs | ₹19.20m | 0.026% ₹ 47.0m | |
| Executive VP of Technical Operations & Director | 1.8yrs | ₹54.50m | no data | |
| Independent Director | 10.1yrs | ₹620.00k | no data | |
| Independent Director | 9.7yrs | ₹350.00k | no data | |
| Independent Director | 9.3yrs | ₹600.00k | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
9.4yrs
Average Tenure
68yo
Average Age
Experienced Board: NATCOPHARM's board of directors are considered experienced (9.4 years average tenure).